Selma Atalay

Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis

Selma Atalay, J.M.P.A. van den Reek, Alfons A den Broeder et al. · JAMA Dermatology · 2020 · 49 citations · Full text

Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort

Jeffrey Zweegers, Britt Roosenboom, P.C.M. van de Kerkhof et al. · British Journal of Dermatology · 2016 · 47 citations

Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial

Selma Atalay, J.M.P.A. van den Reek, Lieke J. van Vugt et al. · BMC Dermatology · 2017 · 19 citations · Full text

Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study

Selma Atalay, J.M.P.A. van den Reek, Marisol E. Otero et al. · Acta Dermato Venereologica · 2020 · 16 citations · Full text

Disease Management, Pharmacotherapy, Standard Psoriasis Care +18

Deficiency of the human cysteine protease inhibitor cystatin M/E causes hypotrichosis and dry skin

Ellen H. van den Bogaard, Michel van Geel, Ivonne M.J.J. van Vlijmen‐Willems et al. · Genetics in Medicine · 2018 · 15 citations · Full text